AIM: Hyperhomocysteinaemia (Hhcy) is known to be an independent risk factor for vascular disease. Coronary flow reserve (CFR) measured by positron emission tomography (PET) is a sensitive method to monitor the effects of pharmacologic interventions in Hhcy...
Keywords: Homocystein, koronare Flussreseve, koronare Herzkrankheit, PET
01/2006 | Nuklearmedizin, Schattauer